
Robert W. Downs
Examiner (ID: 17152)
| Most Active Art Unit | 2308 |
| Art Unit(s) | 2762, 4762, 2309, 2308, 2165 |
| Total Applications | 581 |
| Issued Applications | 448 |
| Pending Applications | 24 |
| Abandoned Applications | 109 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11059616
[patent_doc_number] => 20160256579
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-08
[patent_title] => 'METHOD FOR LABELING A PROSTATE-SPECIFIC MEMBRANE ANTIGEN LIGAND WITH A RADIOACTIVE ISOTOPE'
[patent_app_type] => utility
[patent_app_number] => 15/058537
[patent_app_country] => US
[patent_app_date] => 2016-03-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8268
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15058537
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/058537 | METHOD FOR LABELING A PROSTATE-SPECIFIC MEMBRANE ANTIGEN LIGAND WITH A RADIOACTIVE ISOTOPE | Mar 1, 2016 | Abandoned |
Array
(
[id] => 16128425
[patent_doc_number] => 10697965
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-30
[patent_title] => Method for treating and prognosing cancer
[patent_app_type] => utility
[patent_app_number] => 15/554599
[patent_app_country] => US
[patent_app_date] => 2016-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 15914
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15554599
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/554599 | Method for treating and prognosing cancer | Feb 29, 2016 | Issued |
Array
(
[id] => 12177427
[patent_doc_number] => 20180036364
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-08
[patent_title] => 'METHODS OF TREATING CANCER WITH A PSMA LIGAND-TUBULYSIN COMPOUND'
[patent_app_type] => utility
[patent_app_number] => 15/554866
[patent_app_country] => US
[patent_app_date] => 2016-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 20901
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15554866
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/554866 | METHODS OF TREATING CANCER WITH A PSMA LIGAND-TUBULYSIN COMPOUND | Feb 29, 2016 | Abandoned |
Array
(
[id] => 13265779
[patent_doc_number] => 10144967
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-12-04
[patent_title] => Polymethine compounds and their use as fluorescent labels
[patent_app_type] => utility
[patent_app_number] => 15/058017
[patent_app_country] => US
[patent_app_date] => 2016-03-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10406
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 123
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15058017
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/058017 | Polymethine compounds and their use as fluorescent labels | Feb 29, 2016 | Issued |
Array
(
[id] => 13383655
[patent_doc_number] => 20180243369
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-30
[patent_title] => ALPHA-1-MICROGLOBULIN FOR USE IN THE PROTECTION OF KIDNEYS IN RADIONUCLIDE THERAPY
[patent_app_type] => utility
[patent_app_number] => 15/552478
[patent_app_country] => US
[patent_app_date] => 2016-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10346
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15552478
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/552478 | Alpha-1-microglobulin for use in the protection of kidneys in radionuclide therapy | Feb 24, 2016 | Issued |
Array
(
[id] => 12157431
[patent_doc_number] => 20180028696
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-01
[patent_title] => 'RADIOPHARMACEUTICAL SOLUTIONS WITH ADVANTAGEOUS PROPERTIES'
[patent_app_type] => utility
[patent_app_number] => 15/553298
[patent_app_country] => US
[patent_app_date] => 2016-02-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 14921
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15553298
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/553298 | Radiopharmaceutical solutions with advantageous properties | Feb 23, 2016 | Issued |
Array
(
[id] => 10820528
[patent_doc_number] => 20160166693
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-16
[patent_title] => 'RADIATION ENHANCED MACROMOLECULAR DELIVERY OF THERAPEUTIC AGENTS FOR CHEMOTHERAPY'
[patent_app_type] => utility
[patent_app_number] => 15/049198
[patent_app_country] => US
[patent_app_date] => 2016-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 7815
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15049198
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/049198 | RADIATION ENHANCED MACROMOLECULAR DELIVERY OF THERAPEUTIC AGENTS FOR CHEMOTHERAPY | Feb 21, 2016 | Abandoned |
Array
(
[id] => 12186779
[patent_doc_number] => 20180045715
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-15
[patent_title] => 'STRUCTURE AND FUNCTION OF THE SALICYCLIC ACID BINDING SITES ON HUMAN HMGB1 AND METHODS OF USE THEREOF FOR THE RATIONAL DESIGN OF BOTH SALICYCLIC ACID DERIVATIVES AND OTHER AGENTS THAT ALTER ANIMAL AND PLANT HMGBS ACTIVITIES'
[patent_app_type] => utility
[patent_app_number] => 15/551448
[patent_app_country] => US
[patent_app_date] => 2016-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 18447
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15551448
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/551448 | STRUCTURE AND FUNCTION OF THE SALICYCLIC ACID BINDING SITES ON HUMAN HMGB1 AND METHODS OF USE THEREOF FOR THE RATIONAL DESIGN OF BOTH SALICYCLIC ACID DERIVATIVES AND OTHER AGENTS THAT ALTER ANIMAL AND PLANT HMGBS ACTIVITIES | Feb 11, 2016 | Abandoned |
Array
(
[id] => 15866279
[patent_doc_number] => 20200140543
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-07
[patent_title] => MULTI-SPECIFIC ANTIBODIES WITH AFFINITY FOR HUMAN A33 ANTIGEN AND DOTA METAL COMPLEX AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/549638
[patent_app_country] => US
[patent_app_date] => 2016-02-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30804
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15549638
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/549638 | Multi-specific antibodies with affinity for human A33 antigen and DOTA metal complex and uses thereof | Feb 8, 2016 | Issued |
Array
(
[id] => 12118789
[patent_doc_number] => 20180002375
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-04
[patent_title] => 'PROTEASE-ACTIVATED CONTRAST AGENTS FOR IN VIVO IMAGING'
[patent_app_type] => utility
[patent_app_number] => 15/545689
[patent_app_country] => US
[patent_app_date] => 2016-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 16889
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 14
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15545689
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/545689 | Protease-activated contrast agents for in vivo imaging | Jan 21, 2016 | Issued |
Array
(
[id] => 12562854
[patent_doc_number] => 10016521
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-07-10
[patent_title] => Spect radionuclide-labeled trimeric cycle RGD peptide, preparation method thereof and imaging method thereof
[patent_app_type] => utility
[patent_app_number] => 15/002690
[patent_app_country] => US
[patent_app_date] => 2016-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 3349
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 185
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15002690
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/002690 | Spect radionuclide-labeled trimeric cycle RGD peptide, preparation method thereof and imaging method thereof | Jan 20, 2016 | Issued |
Array
(
[id] => 11009809
[patent_doc_number] => 20160206762
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-21
[patent_title] => 'Agents for the Molecular Imaging of Serine-Protease in Human Pathologies'
[patent_app_type] => utility
[patent_app_number] => 15/001752
[patent_app_country] => US
[patent_app_date] => 2016-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8092
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15001752
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/001752 | Agents for the Molecular Imaging of Serine-Protease in Human Pathologies | Jan 19, 2016 | Abandoned |
Array
(
[id] => 10996391
[patent_doc_number] => 20160193337
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-07
[patent_title] => 'IRON-SALEN COMPLEX'
[patent_app_type] => utility
[patent_app_number] => 14/990981
[patent_app_country] => US
[patent_app_date] => 2016-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 5160
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14990981
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/990981 | Iron-salen complex | Jan 7, 2016 | Issued |
Array
(
[id] => 13714507
[patent_doc_number] => 20170368208
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-28
[patent_title] => CANCER IMAGING AGENT
[patent_app_type] => utility
[patent_app_number] => 15/542230
[patent_app_country] => US
[patent_app_date] => 2016-01-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12476
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15542230
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/542230 | CANCER IMAGING AGENT | Jan 7, 2016 | Abandoned |
Array
(
[id] => 11002577
[patent_doc_number] => 20160199524
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-14
[patent_title] => 'RADIOSENSITIVITY OF FLUOROPHORES AND USE OF RADIOPROTECTIVE AGENTS FOR DUAL-MODALITY IMAGING'
[patent_app_type] => utility
[patent_app_number] => 14/963648
[patent_app_country] => US
[patent_app_date] => 2015-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 37
[patent_no_of_words] => 62703
[patent_no_of_claims] => 47
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14963648
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/963648 | RADIOSENSITIVITY OF FLUOROPHORES AND USE OF RADIOPROTECTIVE AGENTS FOR DUAL-MODALITY IMAGING | Dec 8, 2015 | Abandoned |
Array
(
[id] => 14664943
[patent_doc_number] => 10370362
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-08-06
[patent_title] => Pyrazine derivatives with extended conjugation and methods of using the same in optical applications
[patent_app_type] => utility
[patent_app_number] => 14/962242
[patent_app_country] => US
[patent_app_date] => 2015-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 4
[patent_no_of_words] => 12667
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 272
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14962242
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/962242 | Pyrazine derivatives with extended conjugation and methods of using the same in optical applications | Dec 7, 2015 | Issued |
Array
(
[id] => 11002569
[patent_doc_number] => 20160199519
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-14
[patent_title] => 'Multimodal Imaging of Fibrin'
[patent_app_type] => utility
[patent_app_number] => 14/954236
[patent_app_country] => US
[patent_app_date] => 2015-11-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 16141
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14954236
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/954236 | Multimodal imaging of fibrin | Nov 29, 2015 | Issued |
Array
(
[id] => 13079363
[patent_doc_number] => 10059739
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-08-28
[patent_title] => Non-benzenoid aromatic systems for imaging, monitoring and therapy
[patent_app_type] => utility
[patent_app_number] => 14/950928
[patent_app_country] => US
[patent_app_date] => 2015-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 31309
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 558
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14950928
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/950928 | Non-benzenoid aromatic systems for imaging, monitoring and therapy | Nov 23, 2015 | Issued |
Array
(
[id] => 12246300
[patent_doc_number] => 09919065
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-03-20
[patent_title] => 'Somatostatin analogs with inhibitory activity to growth hormone release'
[patent_app_type] => utility
[patent_app_number] => 14/949473
[patent_app_country] => US
[patent_app_date] => 2015-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18170
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 190
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14949473
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/949473 | Somatostatin analogs with inhibitory activity to growth hormone release | Nov 22, 2015 | Issued |
Array
(
[id] => 10705557
[patent_doc_number] => 20160051704
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-02-25
[patent_title] => 'MOLECULAR IMAGING PROBES FOR LUNG CANCER INTRAOPERATIVE GUIDANCE'
[patent_app_type] => utility
[patent_app_number] => 14/937054
[patent_app_country] => US
[patent_app_date] => 2015-11-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 51
[patent_figures_cnt] => 51
[patent_no_of_words] => 18514
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14937054
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/937054 | MOLECULAR IMAGING PROBES FOR LUNG CANCER INTRAOPERATIVE GUIDANCE | Nov 9, 2015 | Abandoned |